Newfeed

PITTSBURGH, April 29, 2024 /PRNewswire/ — PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, today announced it was selected by X4 Pharmaceuticals, Inc. for the distribution of XOLREMDI™ (mavorixafor), recently approved by the U.S. F

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: